SU2C Dream Teams
Charles L. Sawyers, M.D.Dream Team:
SU2C-PCF Dream Team: Precision Therapy for Advanced Prostate Cancer Targeting PI3K in Women’s Cancers
is an investigator at the Howard Hughes Medical Institute and chairman of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center. He is a past president of the American Society of Clinical Investigation, serves on the nominating committee of the American Association for Cancer Research and on the National Cancer Institute’s Board of Scientific Counselors.
Sawyers attended Princeton University for his undergraduate degree, received his medical degree from Johns Hopkins University School of Medicine in 1985 and completed his postdoctoral studies at the University of California, Los Angeles. He was associate editor for two of the AACR’s journals Cancer Research and Clinical Cancer Research, and currently serves on the editorial board of Cancer Cell.
Sawyers’ research focuses on molecular therapy, with special emphasis on signaling pathway abnormalities in cancer cells as targets for drug therapy. He has received numerous awards for his research including the Emil J. Freireich Award, the AACR-Richard and Hinda Rosenthal Foundation Award, the David A. Karnofsky Award, the Dorothy P. Landon-AACR Prize for Translational Cancer Research and the Bristol-Myers-Squibb “Freedom-to-Explore” Award. Sawyers is also a member of the Institute of Medicine.